Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Lists
Only you see this
Abstract
Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome associated with germline TP53 pathogenic variants. Here, we perform whole-genome sequence (WGS) analysis of tumors from 22 patients with TP53 germline pathogenic variants. We observe somatic mutations affecting Wnt, PI3K/AKT signaling, epigenetic modifiers and homologous recombination genes as well as mutational signatures associated with prior chemotherapy. We identify near-ubiquitous early loss of heterozygosity of TP53, with gain of the mutant allele. This occurs earlier in these tumors compared to tumors with somatic TP53 mutations, suggesting the timing of this mark may distinguish germline from somatic TP53 mutations. Phylogenetic trees of tumor evolution, reconstructed from bulk and multi-region WGS, reveal that LFS tumors exhibit comparatively limited heterogeneity. Overall, our study delineates early copy number gains of mutant TP53 as a characteristic mutational process in LFS tumorigenesis, likely arising years prior to tumor diagnosis.
BibTeX
@inproceedings{light2023germline,
author = {Nicholas Light and Mehdi Layeghifard and Ayush Attery and Vallijah Subasri and Matthew Zatzman and Nathaniel D. Anderson and Rupal Hatkar and Sasha Blay and David Chen and Ana Novokmet and Fabio Fuligni and James Tran and Richard de Borja and Himanshi Agarwal and Larissa Waldman and Lisa M. Abegglen and Daniel J. Albertson and Jonathan L. Finlay and Jordan R. Hansford and Sam Behjati and Anita Villani and Moritz Gerstung and Ludmil B. Alexandrov and Gino R. Somers and Joshua D. Schiffman and Varda Rotter and David Malkin and Adam Shlien},
title = {{Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis}},
booktitle = {Nature Communications},
year = {2023},
doi = {10.1038/s41467-022-35727-y},
}Loading related content...